Подобный материал:
- Российские рекомендации Разработаны Комитетом экспертов Всероссийского научного общества, 1075.77kb.
- Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского, 820.04kb.
- Научная программа организационный комитет почетный председатель съезда оганов Рафаэль, 391.06kb.
- Национальные рекомендации по диагностике и лечению артериальной гипертензии Всероссийское, 609.76kb.
- Отчет о работе iii-й Всероссийской конференции кардиоваскулярная профилактика и реабилитация, 81.18kb.
- Квалификационные тесты по анестезиологии и реаниматологии (полный список), 1728.3kb.
- Доклад Рабочей группы по Глобальному партнерству "Группы восьми", 611.74kb.
- Доклад о работе рабочей группы, 117.21kb.
- Доклад Рабочей группы для Генеральной Ассамблеи оон, 2008, 102.18kb.
- Европейского Кардиологического Общества по лечению больных острыми коронарными синдромами, 941.24kb.
Anumba D.O.C., Robson S.C., Boys R.J., Ford G.A. Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy // Am. J. Physiol. Heart Circ. Physiol. – 1999. – V. 277 (2). – P.848-854.
Ariyuki F. Effects of diltiazem hydrochloride on embryonic development: species differences in the susceptibility and stage specificity in mice, rats, and rabbits // Okajimas Folia Anat. Jpn. - 1975. – V.52. - Р.103-117.
Bae J.H., Bassenge E., Kim K.B. et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress // Atherosclerosis. -2001. – V.155. – P.517–523.
Barker D.J. Fetal origins of cardiovascular disease // Ann. Med. – 1999. – V.31(1). – P.3-6.
Barua R.S., Ambrose J.A., Eales-Reynolds L.J. et al. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation // Circulation. – 2001. – V.104. – P.1905–1910.
Bayliss H., Chuchill D., Beevers M., Beevers D.G. Anti-hypertensive drugs in pregnancy and fetal growth: evidence for «pharmacolical programming» in the first trimester? // Hypertens. Pregnancy. – 2002. – V.21. – P.161-174.
Bian K., Murad F. Nitric oxide (NO) – biogeneration, regulation, and relevance to human diseases // Frontiers in Bioscience. – 2003. – V.8. – P.264-278.
Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk // Arterioscler. Thromb. Vasc. Biology. – 2003. – V.23. – P.168.
Bortolus R., Ricci E., Chatenoud L., Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months // BJOG. – 2000. – V.107(6). – P.792-794.
Brown M.A., Hague W.M., Higgins J. et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Consensus statement from the Australasian Society for the Study of Hypertension in Pregnancy. //Am. J. Obstet Gynecol. - 2000. - V.40. - Р.133-138.
Brunner H., Cockroft J.R., Deanfield J. et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension // J. Hypertension. – 2005. – V.23. – P.233-246.
Burgess A.M., Vere D.W. Teratogenic effects of some calcium channel blocking agents in Xenopus embryos // Pharmacol. Toxicol. – 1989. – V.64. – P.78-82.
Buttar H.S. An overview of the influence of ACE inhibitors on fetal placental circulation and perinatal development // Mol. Cell. Biol. – 1997. – V.176. – P.61-71.
Butters L., Kennedy S., Rubin P.C. Atenolol in essential hypertension during pregnancy // BMJ. – 1990. – V.301. – P.587-589.
Carelton H., Forsythe A., Flores R. Remote prognosis of pre-eclampsia in women 25 years old and younger // Am. J. Obstet. Gynecol. – 1988. – V.159. – P.156-160.
Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis // Lancet. – 1992. – V.340. – P. 1111-1115.
Chambers J.C., Fusi L., Malik I.S. et al. Association of maternal endothelial dysfunction with preeclampsia // JAMA. – 2001. – V.285. – P.1607-1612.
Chesley L.C., Annitto J.E., Cosgrove R.A. The remote prognosis of eclamptic women: sixth periodic report //Am. J. Obstet. Gynecol. – 1976. – V.124. - Р.446–459.
Clausen P., Jensen J.S., Jensen G. et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects // Circulation. – 2001. – V.103. – P.1869.
Cockburn J., Moar V.A., Ounsted M., Redman C.W. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children // Lancet. – 1982. – V.1. – P.647-649.
Сockcroft J.R., Chowienczyk P.J., Brett S.E. et al. Nebivolol vasodilates human foream vasculature: evidence for an L-Arginin/NO-dependent mechanism // J. Pharmac. Exper. Therap. – 1995. – V.274. - №3. – P.1067-1071.
Cockell A.P., Poston L. Flow-Mediated Vasodilatation is Enhanced in Normal Pregnancy but Reduced in Preeclampsia // Hypertension. – 1997. – V.30. – P.247-251.
Collins R., Yusuf S., Peto R. Overview of randomized trials of diuretics in pregnancy // BMJ. – 1985. – V.290. – P.17-23.
Conrad K.P., Joffe G.M., Kruszyna H. et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats // FASEB J. – 1993. – V.7. – P.566-571.
Corretti M.C., Anderson T.J., Benjamin E.J. et al. Guidelines for the Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery // J. Am. Coll. Cardiol. – 2002. - V.39. – P. 257-265.
Crews J.K., Herrington J.N., Granger J.P., Khalil R.A. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat // Hypertension. – 2000. – V.35. – P.367-372.
Crews J.K., Novak J., Granger J.P., Khalil R.A. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats // Am. J. Physiol. Regul. Integr. Comp. Physiol. – 1999. – V.276. – P.530-538.
Cuspidi C., Muiesan M.L., Valagussa L. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the Сandesartan Аssessment in the Treatment of Cardiac Hypertrophy (CATCH) study // J. Hypertens. – 2002. – V.20(11). – P.2293-2300.
Dahlöf B., Devereux R.B., Kjelddsen S.E. et al. Cardiovascular morbidity and mortality in the LIFE study: a randomized trial against atenolol // Lancet. – 2002. – V.359. – P.995-1003.
Davis J.R., Giardina J.B., Green G.M. et al. Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-α-induced hypertension in pregnant rats // Am. J. Physiol. Regul. Integr. Comp. Physiol. – 2002. – V.282 (2). – P.390-399.
Davisson R.L., Hoffmann D.S., Butz G.N. et al. Discovery of a Spontaneous Genetic Mouse Model of Preeclampsia // Hypertension. – 2002. – V.39. – P.337.
Dawes M., Brett S.E., Chowienczyk P.J. et al. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension // British J. Clin. Pharmacol. – 1999. – V.48. – P.460-463.
De Vriese A.S., Verbeuren T.J., Van de Voorde J. et al. Endothelial dysfunction in diabetes // British J. Pharmac. – 2000. - V.130. – P.963-974.
Dørup I., Skajaa K., Sørensen K.E. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation // Am. J. Physiol. Heart Circ. Physiol. - 1999. - Vol. 276. №3. – P.821-825.
Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africe, Asia, Latin America and Caribean // BJOG. – 1992. – V.99. – P.547-553.
Duley L. Preeclampsia and the hypertensive disorders of pregnancy // British Medical Bulletin. – 2003. - V.67. – P.161-176.
Edouard D. A., Pannier B. M., London G. M. et al. Venous and arterial behavior during normal pregnancy // Am. J. Physiol. Heart Circ. Physiol. – 1998. – V.274 (5). – P. 1605-1612.
Eichstädt H., Kaiser W., Möckel M. et al. Haemodynamic measurements in patients under the beta-1 receptor blocker nebivolol // Perfusion. – 1997. – V.12. – P.449-454.
Fisher K.A., Luger A., Spargo B.H., Lindheimer M.D. Hyprtension in pregnancy: clinical-pathological correlations and remote prognosis // Medicine. – 1981. – V.60. – P.267-276.
Flack J.M., Peters R., Mehra V.C., Nasser S.A. Hypertension in special populations // Cardiology Clinics. – 2002. – V.20(2).
Fogari R., Zoppi A/. Lazzari P. et al. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes // J. Hum. Hypertens. – 1997. – V.11. – P.753-757.
Forte P., Copland M., Smith L. et al. Basal nitric oxide synthesis is reduced in essential hypertension // Lancet. – 1997. – V.349. – P.837-842.
Frauchiger B., Nussbaumer P., Hugentobler M., Staub D. Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine // Nephrol. Dial. Transplant. – 2000. – V.15(6). – P.827-832.
Furchgott R.F. Evidence supporting the proposal that EDRF is nitric oxide // Thromb. Res. – 1987. – V.5. – P.7.
Furchgott R.F. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide // JAMA. – 1996. – V.276. – P.1186-1188.
Furchgott R.F., Vanhoutte P.M. Endothelium derived relaxing and contracting factors // FASEB J. – 1989. – V.3. – P.2007-2017.
Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation on the arterial smooth muscle by acetylcholine // Nature. – 1980. – V.288. – P.373-376.
Gazzolo D., Visser G.Y., Russo A. et al. Pregnency-induced hypertension, anti-hypertensive drugs and the development of fetal behavioural states // Early Hum. Development. – 1998. – V.50(2). – P.149-157.
Gerstein H.C., Mann J.F.E., Yi Q. et al. Albuminuria fnd risk of cardiovascular events, death, andheart failure in diabetic and nondiabetic individuals // JAMA. – 2001. – V.286(4). – P.421-426.
Ghiadoni L., Donald A.E., Cropley M. et al. Mental stress induces transient endothelial dysfunction in humans // Circulation. – 2000. – V.102. – P.2473–2478.
Gifford R.W., August P.A., Cunningham G. et al. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy // Am. J. Obstet. Gynecol. – 2000. – V.183. – №1. – P.1-22.
Gilbert W.M., Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction // Am. J. Obstet. Ginecol. – 2003. – V.188. –P.1596-1599.
Goeschen K., Henkel E., Behrens O. Plasma prostacycline and thromboxane concentration in 160 normotensive, hypotensive and preeclamptic patients during pregnancy, delivery and the post partum period // J. Perionat. Med. – 1993. – V.21 (6). – P.481-489.
Gómez-Cerezo J., Blanco J.J.R., García I.S. et al. Noninvasive Study of Endothelial Function in White Coat Hypertension // Hypertension. – 2002. –V.40. – P.304.
Grandi A.M., Broggi R., Colombo S. et al. Left ventricular changes in isolated office hypertension // Arch. Intern. Med. – 2001. – V.161. – P.2677-2681.
Greene M.F. Magnesium Sulfate for Preeclampsia // New Eng. J. Medic. – 2003. – V.348. – P.275-276.
Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertension. – 2003. – V.21. -№6. – P.1011-1053.
Hall D.R., Odendaal H.J., Steyn D.M., Smith M. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomized controlled trial // BJOG. – 2000. – V.107(6). – P.759-765.
Hanssens M., Keirse M.J., Vankelecom F., Van Assche F.A. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy // Obstet. Gynecol. – 1991. – V.78. – P.128-135.
Harake B., Gilbert R.D., Ashwal S., Power G.G. Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep // Am. J. Obstet. Gynecol. – 1987. – V.157(4). – P.1003-1008.
Hardy R., Kuh D., Langenberg C., Wadsworth M.E.J. Birthweight, childhood social class, and change in adult blood pressure in the 1946 British birth cohort // Lancet. – 2003. – V.362. – P.1178-1183.
Hashimoto M., Akishita M., Eto M. et al. Modulation of Endothelium-Dependent Flow-Mediated Dilatation of the Brachial Artery by Sex and Menstrual Cycle // Circulation. – 1995. – V.92. – P.3431-3435.
Helenon O., el-Rody F., Correas J.M. et al. Color Doppler US of renovascular disease in native kidneys // Radiographics. – 1995. – V.15. – P.833-854.
Helewa M.E., Burrows R.F., Smith J. et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive discorderes in pregnancy // CMAJ. – 1997. – V.157. – №6. - P.715-725.
Hillege H.L., Fidler V., Diercks G.F.H. et al. for the Prevention of Renal and Vascular End Stage Disease (PREVEND) study group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population // Circulation. – 2002. – V.106(14). – P.1777-1782.
Hubel C.A., Snaedal S., Ness R.B. et al. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia // BJOG. – 2000. – V.107. – P.776-784.
Ignarro L.J., Byrns R.E., Wood K.S. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarly to nitric oxide radical. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothelium // New York.: Raven Press, 1988. – P.427-436.
Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks // BJOG. – 1993. – V.100. – P.956-961.
Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study // BMJ. – 2001. – V.323 (24). – Р.1213-1217.
John S., Schmeider R.E. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences // J. Hypertension. – 2000. – V.18. – P.363-374.
Kawagishi T., Matsuyoshi M., Emoto M. et al. Impaired Endothelium-Dependent Vascular Responses of Retinal and Intrarenal Arteries in Patients with Type 2 Diabetes // Arteriosc. Thromb. Vasc. Biol. – 1999. – V.19. – P.2509-2516.
Kenny L.C., Baker P.N., Kendall D.A. et al. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and preeclampsia // Clinical Science. – 2002. – V.103. – P.67-73.
Khalil R.A., Crews J.K., Novak J. et al. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats // Hypertension. – 1998. – V.31. – P.1065-1069.
Khalil R.A., Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models // Am. J. Physiol. Regul. Integr. Comp. Physiol. – 2002. – V.283. - №1. – P.29-45.
Kim S.H., Kim S. M., Lee H.K. et al. Diabetic nephropathy: duplex Doppler ultrasound findings // Diab. Res. Clin. Pract. – 1992. – V.18. – P.75-81.
Kincaid-Smith P., Bullen M., Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy // BMJ. – 1966. – V.1. – P.274-276.
Klockenbusch W., Goecke T.W., Krussel J.S. et al. Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia // Gynecol. Obstet. Invest. – 2000. – V.50. – P.103-107.
Knedun S.M., Maharaj B., Moodley J. Effects of antihypertensive drugs on the unborn child. What is known, and how should this influence prescribing? // Paediatr. Drugs. – 2000. – V.2. – P.419-436.
Lain K.Y., Roberts M. Contemporary concepts of the pathogenesis and management of preeclampsia // JAMA. – 2002. – V.287. – P.3183-3186.
Laivuori H., Tikkanen M.J., Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy // J. Clin. Endocrinol. Metab. – 1996. – V.81. – P.2908-2911.
Langford E.J., de Belder A., Lees C. et al. S-Nitrosoglutathione reduces platelet activation and hypertension in severe pre-eclampsia // Eur. Heart J. – 1996. – V.17(10). – P.153.
Lenfant C. Гипертензия и ее последствия: состояние проблемы в мире // Артериальная гипертензия. – 2005. - №2. – С.86-90.
Levin A.C., Doering P.L., Hatton R.C. Use of nifedipine in the hypertensive diseases of pregnancy // Ann. Pharmacotherapy. – 1994. – V.28(12). – P.1371-1378.
Levy D., Garrison R.J., Savage D.D. et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study // N. Engl. J. Med. – 1990. – V.322. – P.1561-1566.
Li Y., Zheng J., Bird I.M., Magness R.R. Mechanisms of Shear Stress-Induced Endothelial Nitric-Oxide Synthase Phosphorylation and Expression in Ovine Fetoplacental Artery Endothelial Cells // Biol. Reprod. – 2004. – V.70. – P.785-796.
Lindeberg S., Axelsson O., Jorner U. et al. Prospective controlled five-year follow up study of primiparas with gestational hypertension. //Acta Obstet. Gynecol. Scand. – 1998. – V.67. – P.605-609.
Lindheimer M.D., Akbari A. Hypertension in pregnant women. In: Oparil S., Weber M.S., ed. Hypertension: A companion to Brenner and Rector’s: The kidney Philadelphia: W.B. Saunders Co. – 2000. – P.688-701.
Lip G.Y.H., Beevers M., Churchill D. et al. Effect of atenolol on birth weight // Am. J. Cardiol. – 1997. – V.79. – P.1436-1438.
Lusher T.E., Barton M. Biology of the endothelium // Clin. Cardiol. – 1997. – V.10. – P.3-10.
Magee L.A. Treating hypertension in women of child-bearing age and during pregnancy // Drug Safety. – 2001. – V.24. – P.457-474.
Magee L.A., Cham C., Waterman E.J. et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis // BMJ. – 2003. – V.327. – P.955.
Magee L.A., Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy // Cochrane Database Syst. Rev. – 2003. – 3:CD002863.
Magee L.A., Koren G. The use of teratogen information services for research: assessment of reliability of data entry // Reprod. Toxicol. - 1994. – V.8. - Р.419-424.
Magee L.A., Ornstein M.P., von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. // BMJ. - 1999. – V.318. - Р. 1332-1336.
Magee L.A., Schick B., Donnenfeld A.E. et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study // Am. J. Obstet. Gynecol. - 1996. - V.174. - Р.823-828.
Maiorano G., Bartolomucci F., Contursi V. et al. Noninvasive detection of vascular dysfunction in alcoholic patients // Am. J Hypertens. – 1999. – V.12. – P.137–144.
Maisch B. Ventricular remodelling // Cardiology. – 1996. –V.87(1). – P.2-10.
Malhotra M., Sharma J.B. et al. Eclampsia is not a sign of latent hypertension // BMJ. - 2003. - V.20. – P.989-1000.
Mancia G., Carugo S., Grassi G. et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control // Hypertension. – 2002. – V.39. – P.744-749.
Mann J.F.E., Gerstein H.C., Qi-Long Y. et al. Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized trial // J. Am. Soc. Nephrol. – 2003. – V.14(3). – P.641-647.
Manninen A. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy // Pharmac. Toxicol. – 1996. – V.78(6). – P.387-391.
Mc Cartney C.P. Pathological anatomy of acute hypertension of pregnancy // Circulation. – 1964. – V.30 (II). – P.37-42.
Mesa A., Jessurun C., Hernandez A. et al. Left Ventricular Diastolic Function in Normal Human Pregnancy // Circulation. – 1999. – V.99. – P.511-517.
Molnar M., Hertelendy F. N
-nitro L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy induced refractoriness to vasopressor agents // Am. J. Obstet. Gynecol. – 1992. - V.166. – P.1560-1567.
Molnar M., Suto T., Toth T., Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation // Am. J. Obstet. Gynecol. – 1994. – V.170. – P.1458-1466.
Mone S.M., Sanders S.P., Colan S.D. Control Mechanisms for Physiological Hypertrophy of Pregnancy // Circulation. – 1996. – V.94. – P.667-672.
Montan S., Anandakumar C., Arulkumaran S. et al. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension // Am. J. Obstet. Gynecol. – 1993. – V.168. – P.152-156.
Mulrow C.D., Chiquette E., Ferrer R.L. et al. Management of chronic hypertension during pregnancy. // USA: Agency for Healthcare Research and Quality. Evidence Report/Tech. - 2000. - Р.201-208.
Myerson S.G., Bellenger N.G., Pennell D.J. Assessment of left ventricular mass by cardiovascular magnetic resonance // Hypertension. – 2002. – V.39. – P.750-755.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification // Am. J. Kidney Dis. – 2002. – V.39 (2, suppl.1). – P.1-266.
Ness R.B., Roberts J.M. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications // Am. J. Obstet. Gynecol. – 1996. – V.175. – P.1365-1370.
Novelli G.P., Valensise H., Vasapollo B. et al. Left Ventricular Concentric Geometry as a Risk Factor in Gestational Hypertension // Hypertension. – 2003. – V.41. – P.469.
Ong K.K., Dunger D.B. Birth weight, infant growth and insulin resistance // Eur. J. Endocrinol. – 2004. – V.151 (3). – P.131-139.
Oslen M.H., Wachtell K., Herman K.L. et al. Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery with longstanding hypertension. A LIFE substudy // Blood Pressure. – 2002. – V.11. - 285-292.
Oyre S., Flagoy H., Hansen M.S. et al. A new MRI method for measuring endothelial function in the brachial artery: comparison with standart ultrasound technique // Eur. Heart J. – 2000. - V.21. – P.67.
Page R.L. Treatment of arrhythmias during pregnancy // Am. Heart J. – 1995. – V.130. – P.871-876.
Palmieri V., Wachtell K., Gerdts E. et al. Left ventricular function and homodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: The LIFE Study // Am. Heart J. – 2001. – V.141. – P.789-791.
Panza J.A., Garcia C.E., Kilcoyne C.M. et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway // Circulation. – 1995. – V.91. – P.1732–1738.
Pedrinelli R. Endothelial vasomotor dysfunction in hypertension // J. Hum. Hypertens. – 2000. – V.14. – P.481-493.
Pedrinelli R., Giampietro O., Carmassi F. et al. Microalbuminuria and endothelial dysfunction in essential hypertension // Lancet. – 1994. – V.344. – P.14-19.
Peek M.J., Horvath J.S., Child A.G. et al. Maternal and neonatal outcome of patients classified according to the Australian Society for the Study of Hypertension in Pregnancy Consensus Statement // Med. J. Aust. – 1995. – V.162(4). – P.186-189.
Piper J.M., Ray W.A., Rosa F.W. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors // Obstet. Gynecol. – 1992. – V.80. – P.429-432.
Platt J.F. Duplex Doppler evaluation of native kidney dysfunction: obstructive and nonobstructive disease // AJR. – 1992. – V.158. – P.1035-1042.
Poppas A., Shroff S.G., Korcarz C.E. et al. Serial Assessment of the Cardiovascular System in Normal Pregnancy. Role of Arterial Compliance and Pulsatile Arterial Load // Circulation. – 1997. – V.95. – P.2407-2415.
Pouta A., Hartikainen A.L., Sovio U. et al. Manifestations of metabolic syndrome after hypertensive pregnancy // Hypertension. – 2004. – V.43(4). – P.825-831.
Pruyn S.C., Phelan J.P., Buchanan G.C. Long-term propranolol therapy in pregnancy. Maternal and fetal outcome // Am. J. Obstet. Gynecol. – 1979. – V.135. – P.485-489.
Radermacher J., Ellis S., Haller H. Renal Resistance Index and Progression of Renal Disease // Hypertension. – 2002. – V.39(2). – P.699.
Radermacher J., Mengel M., Ellis S. et al.
